Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Akcea Therapeutics
Akcea Therapeutics
(AKCA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tegsedi
Inotersen
2018-10-05
2025-2031
Amyloidosis
,
Familial amyloid neuropathies
Waylivra
Volanesorsen
2019-05-03
Hyperlipoproteinemia type i
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Volanesorsen
cardiovascular abnormalities
,
hyperlipoproteinemia type i
,
syndrome
,
hyperlipidemias
,
hyperlipoproteinemia type v
,
hyperlipoproteinemias
,
lipodystrophy
,
familial partial lipodystrophy
,
hypertriglyceridemia
Inotersen
amyloidosis
,
familial amyloid neuropathies
,
pregnancy
Sodium chloride
healthy volunteers/patients
,
contraception
,
pregnancy
,
allergic rhinitis
,
rhinitis
,
allergic rhinitis seasonal
,
asthma
,
bronchitis
,
pulmonary eosinophilia
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
migraine disorders
,
sleep wake disorders
Pelacarsen
renal insufficiency
,
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
VUPANORSEN
healthy volunteers/patients
,
hypertriglyceridemia
,
hyperlipidemias
,
hyperlipoproteinemias
,
hypercholesterolemia
,
hyperlipoproteinemia type ii
,
lipodystrophy
,
familial partial lipodystrophy
,
liver diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
non-alcoholic fatty liver disease
,
fatty liver
,
hyperlipoproteinemia type v
,
syndrome
,
hyperlipoproteinemia type i
,
dyslipidemias
,
homozygous familial hypercholesterolemia
Endocrine
ovarian neoplasms
,
serous cystadenocarcinoma
,
ovarian epithelial carcinoma
Immunoglubulins
amyloidosis
,
familial amyloid neuropathies
,
covid-19
Trinessa
otitis
,
otitis media
,
otitis externa
,
keratitis
,
blepharitis
,
conjunctivitis
,
bacterial conjunctivitis
,
cataract
,
inflammation
,
cataract extraction
,
intravitreal injections
Tqj230
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use